Cita APA

Yamamoto, T. N., Lee, P., Vodnala, S. K., Gurusamy, D., Kishton, R. J., Yu, Z., . . . Klebanoff, C. A. (2019). T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest.

Chicago Style Citation

Yamamoto, Tori N., et al. "T Cells Genetically Engineered to Overcome Death Signaling Enhance Adoptive Cancer Immunotherapy." J Clin Invest 2019.

Cita MLA

Yamamoto, Tori N., et al. "T Cells Genetically Engineered to Overcome Death Signaling Enhance Adoptive Cancer Immunotherapy." J Clin Invest 2019.